^Purnell JQ, Weyer C (2003). "Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity". Treatments in Endocrinology. 2 (1): 33–47.
doi:
10.2165/00024677-200302010-00004.
PMID15871553.
S2CID8088326.
^Strasser F, Bruera ED (June 2002). "Update on anorexia and cachexia". Hematology/Oncology Clinics of North America. 16 (3): 589–617.
doi:
10.1016/s0889-8588(02)00011-4.
PMID12170570.
^Morley JE (2007). "Weight loss in older persons: new therapeutic approaches". Current Pharmaceutical Design. 13 (35): 3637–47.
doi:
10.2174/138161207782794149.
PMID18220800.
^Fox CB, Treadway AK, Blaszczyk AT, Sleeper RB (April 2009). "Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly". Pharmacotherapy. 29 (4): 383–97.
doi:
10.1592/phco.29.4.383.
PMID19323618.
S2CID6695434.
^Holmes S (July 2009). "A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care". International Journal of Palliative Nursing. 15 (7): 320, 322–6.
doi:
10.12968/ijpn.2009.15.7.43421.
PMID19648846.
^Lang F, Perrier E, Pellet J. [Noradrenergic hypothesis in anorexia nervosa: prospective study using beta-stimulant therapy]. Ann Med Psychol (Paris). 1983;141(8):918-25.
^Purnell JQ, Weyer C (2003). "Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity". Treatments in Endocrinology. 2 (1): 33–47.
doi:
10.2165/00024677-200302010-00004.
PMID15871553.
S2CID8088326.
^Strasser F, Bruera ED (June 2002). "Update on anorexia and cachexia". Hematology/Oncology Clinics of North America. 16 (3): 589–617.
doi:
10.1016/s0889-8588(02)00011-4.
PMID12170570.
^Morley JE (2007). "Weight loss in older persons: new therapeutic approaches". Current Pharmaceutical Design. 13 (35): 3637–47.
doi:
10.2174/138161207782794149.
PMID18220800.
^Fox CB, Treadway AK, Blaszczyk AT, Sleeper RB (April 2009). "Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly". Pharmacotherapy. 29 (4): 383–97.
doi:
10.1592/phco.29.4.383.
PMID19323618.
S2CID6695434.
^Holmes S (July 2009). "A difficult clinical problem: diagnosis, impact and clinical management of cachexia in palliative care". International Journal of Palliative Nursing. 15 (7): 320, 322–6.
doi:
10.12968/ijpn.2009.15.7.43421.
PMID19648846.
^Lang F, Perrier E, Pellet J. [Noradrenergic hypothesis in anorexia nervosa: prospective study using beta-stimulant therapy]. Ann Med Psychol (Paris). 1983;141(8):918-25.